tiprankstipranks
Advertisement
Advertisement
Black Diamond Therapeutics reports Q4 EPS (27c), consensus (17c)
PremiumThe FlyBlack Diamond Therapeutics reports Q4 EPS (27c), consensus (17c)
4M ago
BDTX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
BDTX Upcoming Earnings Report: What to Expect?
4M ago
Black Diamond Therapeutics price target lowered to $8 from $9 at Piper Sandler
Premium
The Fly
Black Diamond Therapeutics price target lowered to $8 from $9 at Piper Sandler
6M ago
Black Diamond Therapeutics downgraded to Neutral from Buy at Guggenheim
PremiumThe FlyBlack Diamond Therapeutics downgraded to Neutral from Buy at Guggenheim
7M ago
Promising Potential of Silevertinib in EGFR-Mutant NSCLC: Buy Rating Reiterated
Premium
Ratings
Promising Potential of Silevertinib in EGFR-Mutant NSCLC: Buy Rating Reiterated
7M ago
Black Diamond Reports Promising Phase 2 Lung Cancer Data
Premium
Company Announcements
Black Diamond Reports Promising Phase 2 Lung Cancer Data
7M ago
Black Diamond Therapeutics Reports Positive Financial Turnaround
PremiumCompany AnnouncementsBlack Diamond Therapeutics Reports Positive Financial Turnaround
8M ago
Black Diamond Therapeutics reports Q3 EPS (15c), consensus (23c)
Premium
The Fly
Black Diamond Therapeutics reports Q3 EPS (15c), consensus (23c)
8M ago
Black Diamond Therapeutics sees cash runway into 4Q27
Premium
The Fly
Black Diamond Therapeutics sees cash runway into 4Q27
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100